TP53 and colonic neoplasm: Mono-hydroxymethyl derivatives with S-configuration stood out for their high antiproliferative activity in colon cancer cells expressing WTp53, with IC50 < 1 μM, higher activity than the corresponding enantiomers and MANIO, but no p53-dependent growth-inhibitory effect.